THE PHARMACOKINETICS OF RECOMBINANT ERYTHROPOIETIN IN CAPD PATIENTS

被引：0
|
作者：
MACDOUGALL, IC [1 ]
COLES, GA [1 ]
WILLIAMS, JD [1 ]
机构：
[1] CARDIFF ROYAL INFIRM,KRUF INST RENAL DIS,CARDIFF CF2 1SZ,S GLAM,WALES
来源：
KIDNEY INTERNATIONAL | 1989年 / 35卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：273 / 273
页数：1
相关论文
共 50 条
  • [1] PHARMACOKINETICS OF INTRAVENOUS, INTRAPERITONEAL, AND SUBCUTANEOUS RECOMBINANT ERYTHROPOIETIN IN PATIENTS ON CAPD - A RATIONALE FOR TREATMENT
    MACDOUGALL, IC
    ROBERTS, DE
    NEUBERT, P
    DHARMASENA, AD
    COLES, GA
    WILLIAMS, JD
    ERYTHROPOIETIN : FROM MOLECULAR STRUCTURE TO CLINICAL APPLICATION, 1989, 76 : 112 - 121
  • [2] SUBCUTANEOUS RECOMBINANT ERYTHROPOIETIN IN THE TREATMENT OF RENAL ANEMIA IN CAPD PATIENTS
    MACDOUGALL, IC
    CAVILL, I
    DAVIES, ME
    HUTTON, RD
    COLES, GA
    WILLIAMS, JD
    ERYTHROPOIETIN : FROM MOLECULAR STRUCTURE TO CLINICAL APPLICATION, 1989, 76 : 219 - 226
  • [3] CLINICAL USE OF RECOMBINANT-HUMAN-ERYTHROPOIETIN IN HEMODIALYSIS AND CAPD PATIENTS
    STEVENS, JM
    WINEARLS, CG
    NEFROLOGIA, 1990, 10 : 38 - 43
  • [4] THE TREATMENT OF RENAL ANEMIA IN CAPD PATIENTS WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN
    MACDOUGALL, IC
    DAVIES, ME
    HUTTON, RD
    CAVILL, I
    LEWIS, NP
    COLES, GA
    WILLIAMS, JD
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1990, 5 (11) : 950 - 955
  • [5] COMPARATIVE PHARMACOKINETICS OF RECOMBINANT ERYTHROPOIETIN ADMINISTERED BY THE INTRAVENOUS, SUBCUTANEOUS, AND INTRAPERITONEAL ROUTES IN CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS (CAPD) PATIENTS
    BOELAERT, JR
    SCHURGERS, ML
    MATTHYS, EG
    BELPAIRE, FM
    DANEELS, RF
    DECRE, MJ
    BOGAERT, MG
    PERITONEAL DIALYSIS INTERNATIONAL, 1989, 9 (02): : 95 - 98
  • [6] Efficacy of recombinant human erythropoietin administered subcutaneously to CAPD patients once weekly
    Frifelt, JJ
    Tvedegaard, E
    Bruun, K
    Steffensen, G
    Cintin, C
    Breddam, M
    Dominguez, H
    Jorgensen, JD
    PERITONEAL DIALYSIS INTERNATIONAL, 1996, 16 (06): : 594 - 598
  • [7] EFFECTS OF LONG-TERM TREATMENT WITH HUMAN RECOMBINANT ERYTHROPOIETIN IN PATIENTS ON CAPD
    STEINHAUER, HB
    NEW PERSPECTIVES IN HEMODIALYSIS, PERITONEAL DIALYSIS, ARTERIOVENOUS HEMOFILTRATION, AND PLASMAPHERESIS, 1989, 260 : 157 - 165
  • [8] The Pharmacokinetics of Recombinant Human Erythropoietin in Balkan Endemic Nephropathy Patients
    Lezaic, Visnja
    Petkovic, Nenad
    Maric, Ivko
    Miljkovic, Branislava
    Vucicevic, Katarina
    Simic-Ogrizovic, Sanja
    Pejovic, Vesna
    Djukanovic, Ljubica
    NEFROLOGIA, 2013, 33 (04): : 478 - 485
  • [9] PHARMACOKINETICS OF RECOMBINANT HUMAN ERYTHROPOIETIN IN CHRONIC-HEMODIALYSIS PATIENTS
    NIELSEN, OJ
    PHARMACOLOGY & TOXICOLOGY, 1990, 66 (02): : 83 - 86
  • [10] PHARMACOKINETICS AND DISTRIBUTION OF RECOMBINANT ERYTHROPOIETIN IN RATS
    KINOSHITA, H
    OHISHI, N
    KATO, M
    TOKURA, S
    OKAZAKI, A
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 1992, 42-1 (02): : 174 - 178
12345